Andrew Aromando insider trades

Open-market stock purchases and sales by Andrew Aromando, Chief Business Officer at Oncolytics Biotech Inc, from SEC Form 4 filings since Apr 28, 2023.

Recent trades

DateStockTradeValue
Jun 1, 2026ONCY Oncolytics Biotech IncBought (not open market)—
Feb 11, 2026ONCY Oncolytics Biotech IncBought$25.4K

Companies traded

  • ONCY Oncolytics Biotech Inc: 1 buy, last Jun 1, 2026
  • AMAM Ambrx Biopharma, Inc: other filings, last Mar 7, 2024

Get free alerts when Andrew Aromando files a new trade →